Current Patterns of Management of Advanced Prostate Cancer in Routine Clinical Practice in Spain

Abstract

Objective. To describe urologists' practice patterns when managing patients with advanced prostate cancer (PCa) in Spain. Methods. This was an observational study conducted by 120 urologists using retrospective data of advanced PCa patients attending hospitals and outpatient centers. Results. Urologists evaluated a total of 375 patients (mean age: 75 years; ECOG 0-1: 77%; mean serum PSA levels at study entry: 50.5 ng/Ml). Approximately 50% of patients had bone metastases, and 60.6% experienced pain as the main symptom of progressive disease. Primary androgen deprivation therapy (ADT) use was 99.7%, with continuous ADT as the dominant strategy (91.9%). After failure of initial ADT, antiandrogen withdrawal was the next method most commonly used in 57% of patients. Choice of secondary hormonal treatment was made mostly by urologists (96%), who continued to monitor patients. Patient follow-up after chemotherapy and supportive care were mainly done in urology units, although responsibility was shared with medical oncologists and radiologists. Conclusion. The urologists' attitudes towards management of PCa in the routine practice in Spain show the urologist as an integral component even when patients progress to advanced stages of the disease.

Treatment Patterns and Trends in Patients Dying of Prostate Cancer in Quebec: A Population-Based Study

“…Use of chemotherapy showed an upward trend after 2005, with a peak in 2009, which could be explained by a slow uptake of docetaxel. On average, chemotherapy use remained low in our cohort, with an overall penetrance of less than 25%, similar to usage rates reported in other observational studies 24,25,42 . The high proportion of patients more than 75 years of age in our population could partly explain the low rate of chemotherapy use overall.…”

“…Other real-world studies have shown similar patterns, with secondary hormonal therapy being largely used as the only therapeutic intervention during the mcrpc period [40][41][42] . Chemotherapy was prescribed more frequently in younger patients; all other crpc treatments showed a smaller variation with age.…”

Nomograms predict survival benefits of radical prostatectomy and chemotherapy for prostate cancer with bone metastases: A SEER‐based study

“…Advances in surgery, radiation, and chemotherapy have increased opportunities to diagnose and manage early-stage prostate cancer ( 15 ). However, there is no consensus currently on the clinical treatment selection protocols for the bone-metastatic PCa patients to extend their life expectancy ( 16 ).…”

Different spatial pattern of municipal prostate cancer mortality in younger men in Spain

“…PC is also a tumor with higher variability in its indication and types of treatment[33]. This is due to a combination of different social, organizational, and clinical factors, which may strongly influence the spatial distribution of PC risk.…”